reveromycin a has been researched along with Lung Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fotovati, A; Hiraoka, K; Hosoi, F; Iguchi, H; Kimura, YN; Kuwano, M; Nagata, K; Ono, M; Osada, H; Shoda, T; Watari, K; Zenmyo, M | 1 |
| Kakiuchi, S; Kawatani, M; Muguruma, H; Osada, H; Sone, S; Uehara, H; Yano, S | 1 |
| Sone, S; Yano, S | 1 |
1 review(s) available for reveromycin a and Lung Neoplasms
| Article | Year |
|---|---|
Molecular pathogenesis and its therapeutic modalities of lung cancer metastasis to bone.
Topics: Apoptosis; Bone Neoplasms; Diphosphonates; Humans; Lung Neoplasms; Osteoclasts; Pyrans; Spiro Compounds; Vascular Endothelial Growth Factor Receptor-2 | 2007 |
2 other study(ies) available for reveromycin a and Lung Neoplasms
| Article | Year |
|---|---|
Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages.
Topics: Animals; Bone Density Conservation Agents; Bone Neoplasms; Clodronic Acid; Disease Models, Animal; Female; Humans; Lung Neoplasms; Macrophages; Mice; Mice, Inbred BALB C; Monocytes; Muscle Neoplasms; Neoplasm Invasiveness; Pyrans; Spiro Compounds | 2008 |
Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activity.
Topics: Animals; Antibiotics, Antineoplastic; Bone Neoplasms; Carcinoma, Small Cell; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; Mice; Mice, SCID; Osteoclasts; Parathyroid Hormone-Related Protein; Pyrans; Spiro Compounds; Vascular Endothelial Growth Factor A | 2005 |